Newsfeeds Archive - Spark Newswire

1 minute read

Cue Biopharma Presents Updated Data From Phase 1 Trial of CUE-101 In Recurrent/Metastatic HPV+ Head And Neck Cancer At ASCO 2024

June 4, 8:10 AM

Overall response rate (ORR) of 46% and 12-month overall survival (OS) of 96% in first line (1L) recurrent/metastatic (R/M) HPV+ head and neck squamous cell carcinoma (HNSCC) treated with CUE-101 and

CUE

2 minute read

Movers

12 Health Care Stocks Moving In Thursday’s After-Market Session

By Benzinga Insights

May 2, 4:31 PM

Gainers Twist Bioscience (NASDAQ:TWST) stock increased by 14.1% to $36.51 during Thursday’s after-market session. The company’s market cap…

ALLR

3 minute read

Analyst Ratings

Forecasting The Future: 4 Analyst Projections For Cue Biopharma

By Benzinga Insights

April 9, 10:01 AM

Throughout the last three months, 4 analysts have evaluated Cue Biopharma (NASDAQ:CUE), offering a diverse set of opinions…

CUE

1 minute read

Movers

12 Health Care Stocks Moving In Monday’s After-Market Session

By Benzinga Insights

January 1, 5:30 PM

Gainers NGM Biopharmaceuticals (NASDAQ:NGM) shares moved upwards by 43.2% to $1.23 during Monday’s after-market session. The company’s market…

ADTX

7 minute read

Cue Biopharma Presents New Data From Phase 1 Trials Of CUE-101 In Head and Neck Cancer And CUE-102 In Wilms’ Tumor 1 Positive Cancers At SITC 2023

By Benzinga Newsdesk

November 3, 12:04 PM

Overall response rate (ORR) of 47% and disease control rate (DCR) of 65% in first line (1L) recurrent/metastatic HNSCC patients treated with CUE-101 and KEYTRUDA® (pembrolizumab)ORR of 56% in patients with low

CUE

37 minute read

Options

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

October 3, 2:37 PM

On Tuesday, 647 companies set new 52-week lows.

AADI

2 minute read

Cue Biopharma And 2 Other Stocks Under $3 Insiders Are Buying

By Lisa Levin

August 30, 7:49 AM

The Dow Jones closed higher by close to 300 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

CUE

22 minute read

Earnings

Earnings Scheduled For August 9, 2023

By Benzinga Insights

August 9, 4:54 AM

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is estimated to report quarterly earnings at $0.96 per share on revenue of $18.11 billion.

AADI